期刊
INTERNATIONAL JOURNAL OF CARDIOLOGY
卷 290, 期 -, 页码 106-112出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.ijcard.2019.04.078
关键词
Heart failure; Cancer death; Inflammation
资金
- Ministry of Health, Labour, and Welfare, Tokyo, Japan
- Ministry of Education, Culture, Sports, Science, and Technology, Tokyo, Japan
- Agency for Medical Research and Development, Tokyo, Japan [15ek0210043h0001]
Background: Although several factors, including heart failure (HF) and inflammation, are known to increase the incidence of cancer, it remains unknown whether HF may increase cancer mortality, especially with a reference to inflammation. Methods and results: We examined 8843 consecutive cardiovascular patients without a prior history of cancer in our CHART-2 Study (mean 68 yrs., female 30.9%). As compared with patients without HF (Stage A/B, N = 4622), those with HF (Stage C/D, N = 4221) were characterized by higher prevalence of diabetes, previousmyocardial infarction, atrial fibrillation, and stroke. During the median 6.5-year follow-up (52,675 person-years), 282 cancer deaths occurred. HF patients had significantly higher cancer mortality than those without HF in both the overall (3.7 vs, 2.8%, hazard ratio (HR) 1.42, 95% confidence interval (CI) 1.12-1.79, P=0.004) and the propensity score-matched cohorts (HR 1.46, 95% CI 1.10-1.93, P = 0.008), which was confirmed in the competing risk models. The multivariable Cox proportional hazard model in the matched cohort showed that HF was associated with increased cancer mortality in patients with C-reactive protein (CRP) >= 2.0mg/L (HR 1.87, 95% CI 1.18-2.96, P = 0.008) at baseline, but not in those with CRP < 2.0mg/L (HR0.89, 95% CI 0.54-1.45, P=0.64) (P for interaction = 0.03). Furthermore, temporal changes in CRP levels were associated with cancer death in the overall cohort; HF patientswith CRP >= 2.0mg/L at both baseline and 1-year had significantly increased cancer death, while those with CRP = 2.0mg/L at baseline and < 2.0mg/L at 1-year not. Conclusions: These results provide the first evidence that HF is associated with increased cancer death, especially when associated with prolonged inflammation. (C) 2019 Published by Elsevier B.V.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据